Results 251 to 260 of about 2,749,589 (298)

Neuromodulation in Drug Resistant Epilepsy [PDF]

open access: yesAging and disease, 2021
Epilepsy affects approximately 70 million people worldwide, and it is a significant contributor to the global burden of neurological disorders. Despite the advent of new AEDs, drug resistant-epilepsy continues to affect 30-40% of PWE. Once identified as having drug-resistant epilepsy, these patients should be referred to a comprehensive epilepsy center
Naymee Velez-Ruiz
exaly   +4 more sources

Drug-Resistant Epilepsy and Surgery [PDF]

open access: yesCurrent Neuropharmacology, 2017
Epilepsy is a chronic brain disease that is caused by various factors and characterized by recurrent, episodic and temporary central nervous system dysfunction which results due to excessive discharge of brain neurons. In the past decades, despite the continuous development of antiepileptic drugs, there are still many patients with epilepsy progressing
Shui Liu, Ji Yao Sheng, Bingjin Li
exaly   +3 more sources

Drug resistance in epilepsy

The Lancet Neurology, 2023
Drug resistance is estimated to affect about a third of individuals with epilepsy, but its prevalence differs in relation to the epilepsy syndrome, the cause of epilepsy, and other factors such as age of seizure onset and presence of associated neurological deficits.
Emilio Perucca   +3 more
openaire   +2 more sources

Drug-Resistant Epilepsy

New England Journal of Medicine, 2011
Nearly a quarter of patients with seizures have drug-resistant epilepsy. This review examines how this diagnosis should be established and how to recognize pseudoresistance. It explains possible mechanisms of drug-resistant epilepsy and presents treatment strategies.
Patrick, Kwan   +2 more
openaire   +6 more sources

Mechanisms of Apoptosis in Drug-Resistant Epilepsy

Neuroscience and Behavioral Physiology, 2022
Epilepsy is a chronic neurological disease with regular spontaneous seizures associated with neuroinflammatory, autoimmune and neurodegenerative processes. Approximately 40% of patients suffer from drug-resistant epilepsy, which leads to an increased risk of premature death, injury, irreversible brain damage, psychosocial dysfunction, and reduced ...
E.D. Bazhanova, A.A. Kozlov
openaire   +2 more sources

Topiramate for drug-resistant epilepsies

European Journal of Paediatric Neurology, 2000
Topiramate is a new anti-epileptic drug with proven efficacy against partial seizures in adults. A retrospective assessment of the use of topiramate in drug-resistant childhood epilepsy was undertaken. Thirty-four children (median age of 10 years; range 2-18 years) were treated for a median of 9 months (range 6-18 months).
S, Yeung   +3 more
openaire   +2 more sources

The Preoperative Evaluation of Drug-Resistant Epilepsy

Pediatric Neurology, 2020
Antiepileptic drugs afford good seizure control for approximately 70% of individuals with epilepsy. Epilepsy surgery is extremely helpful for appropriate individuals with drug resistance. Since antiquity, trephination was a crude and invasive technique to manage epilepsy.
Dave F, Clarke   +2 more
openaire   +2 more sources

Ciprofloxacin for treatment of drug-resistant epilepsy

Epilepsy Research, 2021
To investigate the efficacy of short-term treatment with ciprofloxacin in alteration of gut microbiota pattern and reduction of seizure frequency in adult patients with drug-resistant epilepsy.In a prospective study, we investigated the effect of a 5-day course of treatment with ciprofloxacin on gut microbiota pattern and seizure frequency of 23 adults
Hamed Cheraghmakani   +7 more
openaire   +2 more sources

Management of Drug-Resistant Epilepsy

Continuum, 2016
This review discusses the definition, evaluation, and management of patients with drug-resistant epilepsy.Drug-resistant epilepsy is defined as a failure of two or more appropriately selected and adequately tried anticonvulsant medications to achieve seizure freedom for a sustained period of time in either monotherapy or polytherapy.
openaire   +2 more sources

Genetics of drug resistance in epilepsy

Current Neurology and Neuroscience Reports, 2005
Drug resistance is a major clinical problem in epilepsy, affecting one in three patients. It is likely to have a complex multifactorial basis, with environmental and genetic contributions. Knowledge of robust genetic factors underlying drug resistance might both improve prediction and permit the development of novel rational treatments for resistance ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy